26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IV. Mature RBC<br />

203<br />

mechanisms would result in ·NO production, vasodilation,<br />

and increased blood flow at sites where SO 2 in RBCs is<br />

low ( Crawford et al. , 2006 ).<br />

RBCs also promote vasodilation by the release <strong>of</strong> micromolar<br />

amounts <strong>of</strong> ATP, an endothelium-dependent vasodilator,<br />

when SO 2 is low. As oxygen is released from OxyHb,<br />

the increased concentration <strong>of</strong> DeoxyHb binds to the cytoplasmic<br />

domain <strong>of</strong> band 3, displacing PFK and other glycolytic<br />

enzymes. It is hypothesized that this results in a<br />

stimulation <strong>of</strong> glycolysis (see Section IV.G), which results<br />

in increased production and release <strong>of</strong> ATP ( Jagger et al. ,<br />

2001 ). The precise mechanism <strong>of</strong> ATP release is unknown,<br />

but band 3 and nucleoside transporter band 4.5 have been<br />

implicated in transport ( Jagger et al. , 2001 ). In addition,<br />

a member <strong>of</strong> the ATP-binding cassette, the cystic fibrosis<br />

transmembrane conductance regulator (CFTR), appears to<br />

mediate a deformation-induced release <strong>of</strong> ATP from RBCs<br />

( Gov and Safran, 2005 ; Sprague et al. , 2005 ), and this<br />

transport mechanism may also play a role in SO 2 -mediated<br />

ATP release ( Jagger et al. , 2001 ). Blood levels <strong>of</strong> ATP<br />

rise and fall within minutes, compared to seconds for . NO<br />

effects. Consequently, . NO and ATP may have complementary<br />

roles in acute local and prolonged systemic hypoxia,<br />

respectively ( Singel and Stamler, 2005 ).<br />

J . Pentose Phosphate Pathway<br />

The pentose phosphate pathway (PPP) generates NADPH,<br />

the major source <strong>of</strong> reducing equivalents in the protection<br />

<strong>of</strong> RBCs against oxidative injury. This pathway also<br />

produces ribose 5-phosphate (R5P), which is required for<br />

adenine nucleotide synthesis ( Eaton and Brewer, 1974 ).<br />

The PPP competes with the EMP for the G6P substrate<br />

( Fig. 7-5 ). Normally only about 5% to 13% <strong>of</strong> glucose<br />

metabolized by RBCs flows through the PPP ( Harvey and<br />

Kaneko, 1976a ), but this flow can be accelerated markedly<br />

by oxidants ( Harvey and Kaneko, 1977 ).<br />

The first step in the metabolism <strong>of</strong> glucose through the<br />

PPP generates NADPH from the oxidation <strong>of</strong> G6P in the<br />

glucose-6-phosphate dehydrogenase (G6PD) reaction. An<br />

additional NADPH is generated from the oxidative decarboxylation<br />

<strong>of</strong> 6-phosphogluconate (6PG) to ribulose 5-<br />

phosphate in the 6-phosphogluconate dehydrogenase (6PGD)<br />

reaction. This is the only known reaction producing CO 2 in<br />

mature RBCs. The remaining reactions in the PPP are nonoxidative<br />

and freely reversible. R5P is produced from ribulose<br />

5-phosphate by the R5P isomerase reaction. The net<br />

effect <strong>of</strong> the metabolism <strong>of</strong> 3 molecules <strong>of</strong> G6P through the<br />

PPP is as follows ( Eaton and Brewer, 1974 ):<br />

3G6P 6NADP<br />

→ 3CO2<br />

2F6P G3P<br />

6NADPH<br />

6H<br />

G6PD is the rate-limiting reaction in the PPP under<br />

physiological conditions. Normally, the G6PD reaction in<br />

intact human RBCs operates at only 0.1% to 0.2% <strong>of</strong> the<br />

maximal enzyme activity, as determined in hemolysates<br />

under optimal conditions. The low rate <strong>of</strong> this reaction in<br />

RBCs occurs because <strong>of</strong> limited substrate availability (especially<br />

NADP ) and because G6PD is strongly inhibited by<br />

NADPH and ATP at physiological concentrations ( Yoshida,<br />

1973 ). The maximal G6PD activities measured in hemolysates<br />

from goat and sheep RBCs are much lower than those<br />

<strong>of</strong> humans or <strong>of</strong> other domestic animals ( Tables 7-2 and 7-3 ).<br />

However, this comparatively low enzyme activity does not<br />

render sheep RBCs unduly susceptible to the hemolytic<br />

effects <strong>of</strong> oxidant drugs ( Maronpot, 1972 ; Smith, 1968 ),<br />

in part because ATP does not inhibit G6PD in this species<br />

( Smith and Anwer, 1971 ).<br />

About 91% <strong>of</strong> total NADP is in the reduced form in<br />

horse RBCs ( Stockham et al. , 1994 ) and 92% to 99% <strong>of</strong><br />

total NADP is NADPH in human RBCs ( Kirkman et al. ,<br />

1986 ; Zerez et al. , 1987 ). NADPH is utilized to reduce oxidized<br />

glutathione to GSH, the substrate for the glutathione<br />

peroxidase reaction, and it is bound to catalase, preventing<br />

and reversing the accumulation <strong>of</strong> an inactive form <strong>of</strong> catalase<br />

that is generated when catalase is exposed to H 2 O 2<br />

(Kirkman et al. , 1987 ). In the presence <strong>of</strong> oxidants, NADPH<br />

is oxidized and the PPP is stimulated because the activities<br />

<strong>of</strong> G6PD and 6PGD are directly related to the concentration<br />

<strong>of</strong> NADP and inversely related to that <strong>of</strong> NADPH ( Yoshida,<br />

1973 ). Glutathione metabolism affects PPP activity via<br />

the glutathione reductase (GR) enzyme, which generates<br />

NADP as a result <strong>of</strong> the reduction <strong>of</strong> GSSG with NADPH<br />

(Fig. 7-5 ).<br />

K . Nature <strong>of</strong> Oxidants in Biology<br />

Reactive oxygen species (ROS) and reactive nitrogen species<br />

(RNS) are produced as products <strong>of</strong> normal cellular<br />

metabolism. They play dual roles as beneficial and deleterious<br />

species. At low to moderate concentrations, . NO and<br />

superoxide ( . O 2<br />

<br />

) free radicals are involved in signal transductions<br />

between cells ( Valko et al. , 2007 ). A free radical<br />

is defined as any species with one or more unpaired electrons.<br />

When generated at higher concentrations in diseased<br />

states, these free radicals (and even more potent oxidative<br />

metabolites they produce) can overwhelm protective systems<br />

within the body, producing cellular injury or destruction<br />

( Valko et al. , 2007 ). The oxidants generated vary in<br />

their overall reactivities, and some are fairly selective for<br />

certain biomolecules (e.g., tyrosine, glutathione, linoleic<br />

acid, and ascorbate) ( Pryor et al. , 2006 ).<br />

Increased amounts <strong>of</strong> endogenous oxidants are generated<br />

in association with various disorders including inflammation<br />

( Lykkesfeldt, 2002 ; Spickett et al. , 1998 ; Weiss<br />

et al. , 1992a ; Weitzman and Gordon, 1990 ), RBC parasites<br />

( Otsuka et al. , 2001 ; Shiono et al. , 2003 ), neoplasia<br />

( Christopher, 1989 ; Della Rovere et al. , 2000 ), diabetes<br />

( Christopher, 1995 ), intense exercise ( Hargreaves et al. ,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!